- Home
- LPSN vs ANEB Comparison
LPSN vs ANEB Comparison
Compare LPSN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- ANEB
- Stock Information
- Founded
- LPSN 1995
- ANEB 2020
- Country
- LPSN United States
- ANEB United States
- Employees
- LPSN N/A
- ANEB N/A
- Industry
- LPSN EDP Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- ANEB Health Care
- Exchange
- LPSN Nasdaq
- ANEB Nasdaq
- Market Cap
- LPSN 93.0M
- ANEB 36.7M
- IPO Year
- LPSN 2000
- ANEB 2021
- Fundamental
- Price
- LPSN $0.85
- ANEB $0.99
- Analyst Decision
- LPSN Hold
- ANEB Buy
- Analyst Count
- LPSN 6
- ANEB 1
- Target Price
- LPSN $1.18
- ANEB $8.00
- AVG Volume (30 Days)
- LPSN 1.7M
- ANEB 18.7K
- Earning Date
- LPSN 11-07-2024
- ANEB 02-11-2025
- Dividend Yield
- LPSN N/A
- ANEB N/A
- EPS Growth
- LPSN N/A
- ANEB N/A
- EPS
- LPSN N/A
- ANEB N/A
- Revenue
- LPSN $334,736,000.00
- ANEB N/A
- Revenue This Year
- LPSN N/A
- ANEB N/A
- Revenue Next Year
- LPSN N/A
- ANEB N/A
- P/E Ratio
- LPSN N/A
- ANEB N/A
- Revenue Growth
- LPSN N/A
- ANEB N/A
- 52 Week Low
- LPSN $0.45
- ANEB $0.80
- 52 Week High
- LPSN $3.98
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- LPSN 44.08
- ANEB 24.99
- Support Level
- LPSN $0.77
- ANEB $1.30
- Resistance Level
- LPSN $0.92
- ANEB $1.39
- Average True Range (ATR)
- LPSN 0.06
- ANEB 0.18
- MACD
- LPSN 0.00
- ANEB -0.03
- Stochastic Oscillator
- LPSN 38.45
- ANEB 23.89
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.